Thermo Fisher and Symphogen continue work to support the development of innovative cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry workflows Read more
Revenue of $964.0 million; 36% reported growth; 34% organic growth GAAP EPS from continuing operations of $1.57; Adjusted EPS of $2.09 WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 28, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 4, 2020. The Company reported... Read more
Thermo Fisher Scientific Expands Direct-to-Patient Clinical Trials Service Offerings End-to-end solution accelerates clinical trials with speed, convenience and quality WALTHAM, Mass., Oct. 27, 2020 /PRNewswire/ — A newly expanded Direct-to-Patient service offering supports decentralized clinical trials to minimize clinical trial length and costs while maximizing patient enrollment and participation rates. The comprehensive offering now includes... Read more
New kit provides highly sensitive and efficient approach for studying mitophagyimpairment in conditions such as Parkinson’s and Alzheimer’s WALTHAM, Mass. – October 26, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the life science industry’s first no wash Ubiquitin phosphorylation at Serine 65 immunoassay for studying defective... Read more
Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection WALTHAM, Mass. –(BUSINESS WIRE)–Oct. 26, 2020– PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro Read more
FRANKLIN LAKES, N.J., Oct. 22, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Patrick Kaltenbach as executive vice president and chief technology officer, and the promotion of Dave Hickey to executive vice president and president, Life Sciences segment, both effective January 1, 2021.... Read more
WASHINGTON, Oct. 22, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended October 2, 2020. All results in this release reflect only continuing operations unless otherwise noted. For the third quarter 2020, net earnings were $883.5 million, or $1.16 per diluted common share which represents a 38.0% year-over-year... Read more
Accessible 3D Single-Molecule Localization Microscopy for Studying Subcellular Organelles and Spatial Multiomics MADISON, Wisc.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the release of the Vutara VXL Super-Resolution Fluorescence Microscopefor nanoscale biological imaging. The new system opens an affordable and easy-to-use path for both core facilities and individual investigators to enter the world of super-resolution... Read more
WALTHAM, Mass., Oct. 21, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2020. Third Quarter 2020 Highlights Third quarter revenue increased 36% to $8.52 billion. Third quarter GAAP diluted earnings per share (EPS) increased 157% to $4.84.... Read more